BioSpace News Archive

Genetown

Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy Congress

Astria Therapeutics, Inc. today announced that it will share STAR-0215 Phase 1a results in an encore presentation at the annual World Allergy Congress on Sunday, December 3 at 10:00am ICT in Bangkok, Thailand.

November 27, 2023
·
6 min read
Genetown

Avilar Therapeutics Receives U.S. Patent for Novel Extracellular Protein Degraders

Avilar Therapeutics today announced that the U.S. Patent and Trademark Office issued U.S. Patent 11,819,551 on November 21, 2023.

November 27, 2023
·
2 min read
Deals

Merge by Merative Partners with Indica Labs to Bring Digital Pathology into Enterprise Imaging Solutions

Merge by Merative, an industry leader in medical imaging solutions, signed an agreement with Indica Labs, a leading provider of AI-powered digital pathology solutions.

November 27, 2023
·
3 min read
Drug Development

Tharimmune Reports Positive Phase 1 Data on TH104, its Lead Therapeutic Candidate, for Chronic Pruritis in Primary Biliary Cholangitis (PBC)

Tharimmune, Inc. announces positive phase 1 data with TH104, a proprietary transmucosal buccal film which easily adheres to the inside of the mouth.

November 27, 2023
·
9 min read
Business

ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call

ImmunoPrecise Antibodies Ltd. is pleased to announce important Board of Director changes and upcoming financial reporting activities.

November 27, 2023
·
7 min read
BioMidwest

Stratasys Partners with Siemens Healthineers in Landmark Research Project to Advance Medical Imaging

Stratasys Ltd. announced it has partnered with Siemens Healthineers to carry out a landmark research project designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography imaging.

November 27, 2023
·
4 min read
FDA

GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio, Inc. today announced that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug (“IND”) application for GRI-0621 for the treatment of IPF.

November 27, 2023
·
7 min read
Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Met Primary Endpoint of Progression-Free Survival in Phase III Trial for First-Line Treatment of Recurrent/Metastatic Cervical Cancer in All-Comer Patients

Akeso (9926. HK) has announced that the AK104-303 Phase III trial, which investigated cadonilimab (Akeso’s PD-1/CTLA-4 bispecific antibody) combined with platinum-based chemotherapy +/- bevacizumab, has met one of its primary endpoints of progression-free survival (PFS) for first-line treatment of recurrent/metastatic cervical cancer (R/M CC), with p-value of less than 0.0001.

November 27, 2023
·
6 min read
Biotech Bay

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

Anixa Biosciences, Inc. today announced that its partner, Cleveland Clinic, has received an “Intention to Grant” notice from the European Patent Office (“EPO”) for the patent application titled “Ovarian Cancer Vaccines.”

November 27, 2023
·
3 min read
Genetown

Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD

Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) (the “Company” or “Spyre”), a development-stage biotechnology company, today announced its name change to Spyre Therapeutics, Inc.

November 27, 2023
·
10 min read